Skip to main content
SWOG logo

User account menu

  • Log in

Main navigation

  • About
    • History & Impact
    • Mission & Values
    • Leadership
    • Support SWOG
    • Join SWOG
    • Policies & Procedures
    • Careers
    • Contact Us
  • The SWOG Network
    • How We Work
    • Our Staff
    • Our Advocates
    • Our Partners
  • News & Events
    • News
    • SWOG Meetings
    • For Press
  • Clinical Trials
    • Biospecimen Submission
    • Biospecimen Access
    • Data Requests
    • Clinical Trials Search
    • Clinical Research Resources
    • Frequently Asked Questions
    • Publications
    • Institutions
    • Quality Assurance & Audits
    • Serious Adverse Events
    • Training Resources
    • ORP (CRA) Workbench
    • Protocol Workbench
  • Workbenches
    • ORP (CRA) Workbench
    • Protocol Workbench
    • VA Workbench
  • For Patients
    • Patient & Advocate Voices
    • Trials Open to Patients
    • About SWOG Cancer Trials
    • Joining a Trial

Breadcrumb

  1. SWOG
  2. News & Events
  3. News
  4. News

News

SIGN UP FOR EMAIL UPDATES

Active Filters

  • The Front LineClear filter
New Front Line
The Front Line
May 29, 2020

SWOG's Pandemic Accrual: Facts and More Facts

New Front Line
The Front Line
May 22, 2020

A Spring of Powerhouse Pubs + Presentations

New Front Line
The Front Line
May 15, 2020

Supporting Stats, Celebrating Crowley

New Front Line
The Front Line
May 1, 2020

Oncology Meetings Make the Switch to Screens

New Front Line
The Front Line
Apr 24, 2020

Our Columbia Team on the COVID Front Lines

New Front Line
The Front Line
Apr 13, 2020

Flattening the Virtual Group Meeting Curve

New Front Line
The Front Line
Apr 10, 2020

COVID-19 Support for Patients with Cancer

New Front Line
The Front Line
Apr 3, 2020

COVID Registry Gets Its Start on Twitter

New Front Line
The Front Line
Mar 27, 2020

COVID-19 Slows Research, But Trials Continue

  • Previous page ‹
  • First page 1
  • …
  • Page23
  • Current page24
  • Page25
  • …
  • Last page 43
  • Next page ›
SWOG logo

Footer: Social Links

  • LinkedIn
  • Twitter
  • YouTube
Copyright © 2026

Footer

  • Disclaimer